Perspective Therapeutics CATX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's interest income?
- Perspective Therapeutics (CATX) reported interest income of $2.2M in Q1 2026.
- How has Perspective Therapeutics's interest income changed year-over-year?
- Perspective Therapeutics's interest income decreased by 7.8% year-over-year, from $2.38M to $2.2M.
- What is the long-term trend for Perspective Therapeutics's interest income?
- Over 2 years (2023 to 2025), Perspective Therapeutics's interest income has grown at a 194.7% compound annual growth rate (CAGR), from $934K to $8.11M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.